Health & Traits Publications

Zagkos L, Schwinges A et al.

Sci Rep

Educational attainment (EA) has been linked to the risk of several types of cancer, despite having n...

Head and neck cancer

Aggarwal P, Hutcheson KA et al.

Sci Rep

Genetic susceptibility for xerostomia, a common sequela of radiotherapy and chemoradiotherapy for he...

Xerostomia (moderate to severe) in oropharyngeal cancer

Schack LMH, Naderi E et al.

Br J Cancer

Purpose: A two-stage genome-wide association study was carried out in head and neck cancer (HNC) pat...

Acute dysphagia (moderate to severe) in head and neck cancer treated with radiotherapy

Naderi E, Crijns APG et al.

J Transl Med

Most head and neck cancer (HNC) patients receive radiotherapy (RT) and develop toxicities. This geno...

radiation-induced toxicity (patient-rated acute xerostomia)

Brooker RC, Antczak P et al.

Radiother Oncol

Background/aim: Utilising radiotherapy in the management of head and neck cancer (HNC) often results...

Mandibular osteoradionecrosis in radiotherapy-treated head and neck cancer

Yang DW, Wang TM et al.

J Transl Med

Radiation-induced oral mucositis (OM) is one of the most common acute complications for head and nec...

Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis)

He Y, Ji P et al.

Front Oncol

As the sixth most common cancer of worldwide, head and neck cancers (HNC) are springing from oral ca...

Head and neck squamous cell carcinoma

Reyes-Gibby CC, Wang J et al.

Sci Rep

Neuropathic pain (NP), defined as pain initiated or caused by a primary lesion or dysfunction in the...

Neuropathic pain in head and neck cancer

Azad AK, Bairati I et al.

Cancer Epidemiol

Carcinomas of the oral cavity, pharynx and larynx are referred to as head and neck cancers (HNC); to...

Survival in head and neck cancer

Chen D, McKay JD et al.

Hum Mol Genet

High-risk α mucosal types of human papillomavirus (HPV) cause anogenital and oropharyngeal cancers, ...

HPV seropositivity

Ziliak D, O'Donnell PH et al.

Transl Res

Identifying patients prior to treatment who are more likely to benefit from chemotherapeutic agents ...

Response to platinum-based chemotherapy in head and neck cancers